A study to look at how safe was it to give people with blood cancer (non-Hodgkin’s lymphoma and chronic lymphocytic leukemia) – different doses of a study medicine (fenebrutinib)
Cancer Non Hodgkin Lymphoma (NHL) Diffuse Large B-Cell Lymphoma (DLBCL) Leukemia Chronic Lymphocytic Leukemia
For the latest version of this information please go to www.forpatients.roche.com